Compare IDEXX Laboratories, Inc. (IDXX) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Quantum Computing Inc — how do they compare? IDEXX Laboratories, Inc. trades at $551.53 (market cap $44.48B), while Quantum Computing Inc trades at $8.14 (market cap $1.79B). The key difference: IDEXX Laboratories, Inc. is far larger — about 24.8× Quantum Computing Inc's market cap. Which is the better fit depends on your goals.
| IDXX | QUBT | |
|---|---|---|
Market Cap | $44.48B | $1.79B |
Sector | Health | Technology |
52-Week High | $766.68 | $24.62 |
52-Week Low | $520.87 | $6.31 |
Enterprise Value | $45.38B | $803.83M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Quantum Computing Inc. (QUBT) trades at $7.92, up 1.54% today, while technical indicators signal a bearish trend. The company shows minimal revenue of $682,000 for 2025 with a net loss of $18.67 million, resulting in negative profit margins. Analysts maintain a bullish consensus with a $26 price target, citing potential from commercial backlog and policy support, despite ongoing cash burn and a recent legal investigation into corporate governance.
QUBT offers high-risk, high-reward potential driven by quantum computing commercialization prospects, but faces significant execution risks and financial instability. The stock's outlook hinges on revenue scaling and managing cash flow, with substantial downside if growth targets are missed.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
